PATENT CLAIM ANALYSIS

Application Number: 16076836
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "443000"]

Abstract:
This invention relates to novel 4,4,5,5,7,7-hexamethyl-5,7-dihydro-4H-thieno[2,3-c]pyranyl compounds, and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering cystic fibrosis transmembrane conductance regulator (CFTR) modulators.

Claim (Index 4):
The compound of  claim 1 , wherein:\n each R 1  is independently CH 3  or CD 3 ; each R 2  is independently CH 3  or CD 3 ; and each R 3  is the same.

Metadata:
- Claim Count in Document: 19.0
- Percentile: 96.0
- Lexical Diversity: 1.18367
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13808508', '13959716', '15562860', '13364724', '14915527']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7670620194414558
- 35 USC 102 Novelty (BERT): 0.5020756163556689
- Combined Prediction Score: 0.7405633791328772
- Mean Citation Score: 246.669346
- Max Citation Score: 253.55965
- Similarity Product: 209.96613302998244

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test